Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Barbara Ann Karmanos Cancer Institute

ClinicalTrials.gov Identifier:

NCT00068653

First received: September 10, 2003

Last updated: April 25, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2008
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)